Cargando…
CYTOMEGALOVIRUS COLITIS POST IL-6 INHIBITOR USE IN COVID-19 INFECTION
Autores principales: | Jiwa, Nasheena, Lorick, Kiran, Mutneja, Rahul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548634/ http://dx.doi.org/10.1016/j.chest.2020.08.719 |
Ejemplares similares
-
Development of a brief scoring system to predict any-cause mortality in patients hospitalized with COVID-19 infection
por: Jiwa, Nasheena, et al.
Publicado: (2021) -
Pneumothorax in Mechanically Ventilated Patients with COVID-19 Infection
por: Akdogan, Raziye Ecem, et al.
Publicado: (2021) -
REACTIVATION OF EPSTEIN-BARR VIRUS AND CYTOMEGALOVIRUS INFECTION IN PATIENTS WITH COVID-19
por: ALMAGUER, ANGELICA, et al.
Publicado: (2022) -
AN UNUSUAL CASE OF CYTOMEGALOVIRUS PNEUMONIA IN A PATIENT WITH COVID-19 REQUIRING EXTRACORPOREAL MEMBRANOUS OXYGENATION
por: SELF, ALYSSA, et al.
Publicado: (2022) -
POST-INFECTIOUS DEMYELINATING POLYNEUROPATHY SECONDARY TO COVID-19 INFECTION
por: PATTI, RAVIKARAN, et al.
Publicado: (2021)